van Eimeren, T., Antonini, A., Berg, D., Bohnen, N., Ceravolo, R., Drzezga, A., Höglinger, G. U., Higuchi, M., Lehericy, S., Lewis, S., Monchi, O., Nestor, P., Ondrus, M.
, Pavese, N., Peralta, M. C., Piccini, P., Pineda-Pardo, J. Á., Rektorová, I., Rodríguez-Oroz, M. ... MDS Neuroimaging Study Group and the JPND Working Group ASAP-SynTau (2019).
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring,
11, 301-309.
https://doi.org/10.1016/j.dadm.2019.01.011
Bhatnagar, M., Cintra, A., Chadi, G., Lindberg, J., Oitzl, M., De Kloet, E. R.
, Møller, A., Agnati, L. F. & Fuxe, K. (1997).
Neurochemical changes in the hippocampus of the brown norway rat during aging.
Neurobiology of Aging,
18, 319-327.
Zou, L.-Q., Zhou, H.-Y., Zhuang, Y., van Hartevelt, T. J., Lui, S. S. Y., Cheung, E. F. C.
, Møller, A., Kringelbach, M. L. & Chan, R. C. K. (2018).
Neural responses during the anticipation and receipt of olfactory reward and punishment in human.
Neuropsychologia,
111, 172-179.
https://doi.org/10.1016/j.neuropsychologia.2018.02.003
Van Hartevelt, T. J.
, Cabral, J., Deco, G.
, Møller, A., Green, A. L., Aziz, T. Z.
& Kringelbach, M. L. (2014).
Neural plasticity in human brain connectivity: The effects of long term deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
P L o S One,
9(1), Article e86496.
https://doi.org/10.1371/journal.pone.0086496
Schmidt, C., Gleesborg, C., Schmidt, H.
, Kvamme, T. L., Voon, V.
& Møller, A. (2023).
Neural fingerprints of gambling disorder using diffusion tensor imaging.
Psychiatry Research - Neuroimaging,
333, Article 111657.
https://doi.org/10.1016/j.pscychresns.2023.111657
Miani, A., Di Bernardo, G. A., Højgaard, A. D., Earp, B. D., Zak, P. J.
, Landau, A. M., Hoppe, J.
& Winterdahl, M. (2020).
Neonatal male circumcision is associated with altered adult socio-affective processing.
Heliyon,
6(11), Article e05566.
https://doi.org/10.1016/j.heliyon.2020.e05566
Thomsen, M., Lillethorup, T. P., Wegener, G., Tasker, A. & Landau, A. M. (2015).
Neonatal domoic acid increases receptor density of α2 adrenoceptors and GABAA α5 receptors in limbic brain regions of adult rats. Poster session presented at 56th Annual Congress of the Scandinavian College of Neuro-Psychopharmacology, Copenhagen, Denmark.
Thomsen, M., Lillethorup, T. P., Jakobsen, S., Nielsen, E. H. T., Simonsen, M.
, Wegener, G., Tasker, A. & Landau, A. M. (2015).
Neonatal domoic acid decreases in vivo binding of [11C]yohimbine to α2 adrenoceptors in adult rat brain. Poster session presented at Brain & Brain PET 2015, Vancouver, Canada.
Thomsen, M., Lillethorup, T. P., Jakobsen, S., Nielsen, E. H. T., Simonsen, M.
, Wegener, G., Tasker, A. & Landau, A. M. (2015).
Neonatal domoic acid decreases in vivo binding of [11C]yohimbine to α2 adrenoceptors in adult rat brain. Poster session presented at NeuroConX, Charlottetown, Prince Edward Island, Canada.
Thomsen, M. B., Lillethorup, T. P., Jakobsen, S., Nielsen, E. H., Simonsen, M.
, Wegener, G., Landau, A. M. & Tasker, A. (2016).
Neonatal domoic acid alters in vivo binding of [(11)C]yohimbine to α2-adrenoceptors in adult rat brain.
Psychopharmacology,
233(21), 3779-3785.
https://doi.org/10.1007/s00213-016-4416-5
Hammers, A., Koepp, M. J., Labbé, C.
, Brooks, D. J., Thom, M., Cunningham, V. J. & Duncan, J. S. (2001).
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy.
Neurology,
56(7), 897-906.
https://doi.org/10.1212/WNL.56.7.897
Al-Aish, M., Coleman, R. E., Larson, S. M., Barrio, J., Brodack, J.
, Brooks, D., Di Chiro, G., Eckelman, W., Fowler, J., Frost, J., Gould, K. L., Krohn, K., Kuhl, D., Marcus, C. S., Martin, W., Mazziotta, J., Mintun, M., Muehllehner, G. & Mullani, N. (1990).
National cancer institute workshop statement. Advances in clinical imaging using positron emission tomography, September 14-16, 1988.
Archives of Internal Medicine,
150(4), 735-739.
https://doi.org/10.1001/archinte.150.4.735
Khan, N. L., Jain, S., Lynch, J. M.
, Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., Gibbons, V., Gandhi, S., Vaughan, J., Eunson, L. H., Katzenschlager, R., Gayton, J., Lennox, G., Revesz, T., Nicholl, D. ... Wood, N. W. (2005).
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: Clinical, pathological, olfactory and functional imaging and genetic data.
Brain,
128(12), 2786-2796.
https://doi.org/10.1093/brain/awh667
Lunde, S. J., Vuust, P., Garza-Villarreal, E. A., Kirsch, I.
, Møller, A. & Vase, L. (2022).
Music-induced analgesia in healthy participants is associated with expected pain levels but not opioid or dopamine-dependent mechanisms.
Frontiers in Pain Research,
3, Article 734999.
https://doi.org/10.3389/fpain.2022.734999
Lillethorup, T. P., GLUD, AN., Jakobsen, S.
, Alstrup, A. K. O., Moeller, A.
, Sørensen, J. C. H., Doudet, D. J.
& Landau, A. M. (2017).
Multi-Neurotransmitter Deficits in a Minipig Model of Parkinson’s Disease. Poster session presented at 1st Annual Research Meeting, Aarhus, Denmark.
Lillethorup, T. P., Glud, A. N., Jakobsen, S.
, Alstrup, A. K. O., Moeller, A.
, Sørensen, J. C. H., Doudet, D. J.
& Landau, A. M. (2017).
Multi-Neurotransmitter Deficits in a Minipig Model of Parkinson´s Disease. Poster session presented at Psykiatriens 12. forskningsdag, Aarhus, Denmark.
Mikkelsen, M.
, Møller, A., Jensen, L. H., Pedersen, A., Harajehi, J. B. & Pakkenberg, H. (1999).
MPTP-Induced parkinsonism in Minipigs: A behavioral, biochemical and histological study.
Neurotoxicology and Teratology,
21, 169-175.
Jenkins, I. H.
, Brooks, D. J., Nixon, P. D., Frackowiak, R. S. J. & Passingham, R. E. (1994).
Motor sequence learning: A study with positron emission tomography.
Journal of Neuroscience,
14(6), 3775-3790.
Steinmüller, J. B., Henrique Binda, K., Lillethorup, T. P., Søgaard, B., Orlowski, D., Landau, A., Bjarkam, C. R.
, Sørensen, J. C. H. & Glud, A. N. (2022).
Motor assessment in translational porcine models by pressure-sensitive gait mat analysis. Poster session presented at Neuroscience 2022 - Society for Neuroscience, San Diego, California, United States.
Farmen, K.
, Nissen, S. K., Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M.
, Otto, M., Svendsen, K. B., Garrido, A., Vilas, D.
, Borghammer, P., Santamaria, J.
, Møller, A., Gaig, C.
, Brooks, D. J., Tolosa, E.
, Pavese, N. & Romero-Ramos, M. (2021).
Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder.
Proceedings of the National Academy of Sciences,
118(10), Article e2020858118.
https://doi.org/10.1073/pnas.2020858118
Dyve, S.
, Landau, A. M., Gjedde, A., Alstrup, A. K. O. & Doudet, D. (2009).
Monoaminergic mechanisms of the therapeutic effects of vagal nerve stimulation. Abstract from Epilepsihospitalet Filadelfia Symposium, Dianalund, Denmark.
Strafella, A. P., Bohnen, N. I., Perlmutter, J. S., Eidelberg, D.
, Pavese, N., Van Eimeren, T., Piccini, P., Politis, M., Thobois, S., Ceravolo, R., Higuchi, M., Kaasinen, V., Masellis, M., Peralta, M. C., Obeso, I., Pineda-Pardo, J. Á., Cilia, R., Ballanger, B., Niethammer, M. ... IPMDS-Neuroimaging Study Group (2017).
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.
Movement Disorders,
32(2), 181-192.
https://doi.org/10.1002/mds.26907
Campbell-Meiklejohn, D.
, Simonsen, A., Jensen, M., Wohlert, V., Gjerløff, T., Scheel-Kruger, J.
, Møller, A., Frith, C. D.
& Roepstorff, A. (2012).
Modulation of Social Influence by Methylphenidate.
Neuropsychopharmacology.
https://doi.org/10.1038/npp.2011.337
Dodel, R., Spottke, A., Gerhard, A., Reuss, A., Reinecker, S., Schimke, N., Trenkwalder, C., Sixel-Döring, F., Herting, B., Kamm, C., Gasser, T., Sawires, M., Geser, F., Köllensperger, M., Seppi, K., Kloss, M., Krause, M., Daniels, C., Deuschl, G. ... Eggert, K. (2010).
Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial).
Movement Disorders,
25(1), 97-107.
https://doi.org/10.1002/mds.22732
Turner, M. R., Gerhard, A., Al-Chalabi, A., Shaw, C. E., Hughes, R. A. C., Banati, R. B.
, Brooks, D. J. & Leigh, P. N. (2005).
Mills' and other isolated upper motor neurone syndromes: In vivo study with 11C-(R)-PK11195 PET.
Journal of Neurology, Neurosurgery & Psychiatry,
76(6), 871-874.
https://doi.org/10.1136/jnnp.2004.047902
Politis, M.
, Pavese, N., Tai, Y. F., Kiferle, L., Mason, S. L.
, Brooks, D. J., Tabrizi, S. J., Barker, R. A. & Piccini, P. (2011).
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
Human Brain Mapping,
32(2), 258-70.
https://doi.org/10.1002/hbm.21008
Tai, Y. F.
, Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A.
, Brooks, D. J. & Piccini, P. (2007).
Microglial activation in presymptomatic Huntington's disease gene carriers.
Brain,
130(7), 1759-1766.
https://doi.org/10.1093/brain/awm044
Banati, R. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F. E.
, Brooks, D. J. & Jones, T. (2000).
Microglial activation in neurodegenerative diseases: A PET study using [11C](R)-PK11195.
NeuroImage,
11(6 PART II).
Femminella, G. D., Dani, M., Wood, M., Fan, Z., Calsolaro, V., Atkinson, R., Edginton, T., Hinz, R.
, Brooks, D. J. & Edison, P. (2019).
Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume.
Neurology,
92(12), E1331-E1343.
https://doi.org/10.1212/WNL.0000000000007133
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A.
, Brooks, D. J. & Piccini, P. (2006).
Microglial activation correlates with severity in Huntington disease: A clinical and PET study.
Neurology,
66(11), 1638-1643.
https://doi.org/10.1212/01.wnl.0000222734.56412.17
Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T.
, Brooks, D. J. & Edison, P. (2018).
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
Brain,
141(9), 2740-2754.
https://doi.org/10.1093/brain/awy188
Staer, K., Iranzo, A.
, Stokholm, M., Ostergaard, K., Serradell, M.
, Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J.
, Moller, A., Gaig, C.
, Brooks, D., Borghammer, P., Tolosa, E.
& Pavese, N. (2020).
Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder.
Movement Disorders,
35(Suppl. S1), S283-S283.
https://doi.org/10.1002/mds.28268
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M.
& Brooks, D. J. (2009).
Microglial activation and amyloid deposition in mild cognitive impairment: A PET study.
Neurology,
72(1), 56-62.
https://doi.org/10.1212/01.wnl.0000338622.27876.0d
Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Ray Chaudhuri, K., Walker, Z., Turkheimer, F. E.
& Brooks, D. J. (2013).
Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
Neuropsychopharmacology,
38(6), 938-49.
https://doi.org/10.1038/npp.2012.255
Edison, P., Archer, H. A., Gerhard, A., Hinz, R.
, Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., Rossor, M.
& Brooks, D. J. (2008).
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
Neurobiology of Disease,
32(3), 412-419.
https://doi.org/10.1016/j.nbd.2008.08.001
Ostrowitzki, S., Deptula, D., Thurfjell, L., Barkhof, F., Bohrmann, B.
, Brooks, D. J., Klunk, W. E., Ashford, E., Yoo, K., Xu, Z.-X., Loetscher, H. & Santarelli, L. (2012).
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.
Archives of Neurology,
69(2), 198-207.
https://doi.org/10.1001/archneurol.2011.1538
Morrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V.
& Brooks, D. J. (1998).
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET.
Journal of Neurology Neurosurgery and Psychiatry,
64(3), 314-319.
https://doi.org/10.1136/jnnp.64.3.314
Brooks, D. J., Lammertsma, A. A., Beaney, R. P., Leenders, K. L., Buckingham, P. D., Marshall, J. & Jones, T. (1984).
Measurement of regional cerebral pH in human subjects using continuous inhalation of 11CO2 and positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
4(3), 458-465.
https://doi.org/10.1038/jcbfm.1984.65
Lammertsma, A. A.
, Brooks, D. J., Frackowiak, R. S. J., Beaney, R. P., Herold, S., Heather, J. D., Palmer, A. J. & Jones, T. (1987).
Measurement of glucose utilisation with [18F]2-fluoro-2-deoxy-D-glucose: A comparison of different analytical methods.
Journal of Cerebral Blood Flow and Metabolism,
7(2), 161-172.
https://doi.org/10.1038/jcbfm.1987.39
Pedersen, K., Simonsen, M.
, Østergaard, S. D., Munk, O. L., Rosa-Neto, P., Olsen, A. K., Jensen, S. B.
, Møller, A. & Cumming, P. (2007).
Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
NeuroImage,
35(1), 38-46.
https://doi.org/10.1016/j.neuroimage.2006.11.038
Horsager, J., Okkels, N., Hansen, A. K.
, Damholdt, M. F., Andersen, K. H.
, Fedorova, T. D., Munk, O. L., Danielsen, E. H., Pavese, N., Brooks, D. J. & Borghammer, P. (2022).
Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [18F]FEOBV PET Case-Control Study.
Journal of Parkinson's Disease,
12(8), 2493-2506.
https://doi.org/10.3233/JPD-223489
Galgani, A., Lombardo, F., Martini, N., Vergallo, A., Bastiani, L., Hampel, H., Hlavata, H., Baldacci, F., Tognoni, G., De Marchi, D., Ghicopulos, I., De Cori, S., Biagioni, F., Busceti, C. L., Ceravolo, R., Bonuccelli, U., Chiappino, D., Siciliano, G., Fornai, F. ... Giorgi, F. S. (2023).
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia.
European Journal of Neurology,
30(1), 32-46.
https://doi.org/10.1111/ene.15556
Parbo, P., Madsen, L. S., Ismail, R., Zetterberg, H., Blennow, K.
, Eskildsen, S. F., Vorup-Jensen, T. & Brooks, D. J. (2020).
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.
Alzheimer's Research & Therapy,
12(1), Article 3.
https://doi.org/10.1186/s13195-019-0574-0
Sabers, A., Bertelsen, F. C. B., Scheel-Krüger, J.
, Nyengaard, J. R. & Møller, A. (2014).
Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism.
Neuroscience Letters,
580, 12-6.
https://doi.org/10.1016/j.neulet.2014.07.036
Banati, R. B., Cagnin, A.
, Brooks, D. J., Gunn, R. N., Myers, R., Jones, T., Birch, R. & Anand, P. (2001).
Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury.
NeuroReport,
12(16), 3439-3442.
https://doi.org/10.1097/00001756-200111160-00012
Nuti, A., Lucetti, C.
, Pavese, N., Dell'Agnello, G., Rossi, G. & Bonuccelli, U. (1996).
Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients.
Cephalalgia,
16(5), 337-340.
https://doi.org/10.1046/j.1468-2982.1996.1605337.x
Doudet, D.
, Landau, A. M., Dyve, S.
, Jakobsen, S., Alstrup, A. K. O. & Gjedde, A. (2011).
Long term decrease in alpha 2 receptor distribution volume after acute stimulation of NA release. Abstract from XXVth International Symposium on Cerebral Blood Flow, Metabolism and Function and the Xth International Conference on Quantification of Brain Function with PET, Barcelona, Spain.
Reuter, I., Tai, Y. F.
, Pavese, N., Chaudhuri, K. R., Mason, S., Polkey, C. E., Clough, C.
, Brooks, D. J., Barker, R. A. & Piccini, P. (2008).
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.
Journal of Neurology, Neurosurgery & Psychiatry,
79(8), 948-951.
https://doi.org/10.1136/jnnp.2007.142380
Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Mollenhauer, B., Owen, A. M., Khoo, T. K.
, Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2017).
Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.
Neurobiology of Aging,
55, 78-90.
https://doi.org/10.1016/j.neurobiolaging.2017.03.012
Lillethorup, T. P., GLUD, AN., Alstrup, A. K. O., Noer, O., Nielsen, E. H. T., Schacht, A. C., Landeck, N., Kirik, D.
, Orlowski, D., Sørensen, J. C. H., Doudet, D. J.
& Landau, A. (2018).
Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs.
Scientific Reports,
8(1), Article 15715.
https://doi.org/10.1038/s41598-018-34084-5
Landau, A. M., Jakobsen, S., Alstrup, A. K. O., Schacht, A. C.
, Winterdahl, M., Møller, A., Sørensen, J. C. H. & Doudet, D. (2013).
Longitudinal in vivo imaging in a novel model of Parkinson’s disease in minipig. Poster session presented at World Parkinson Congress, Montreal, Denmark.
Minett, T., Su, L., Mak, E., Williams, G., Firbank, M., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K.
, Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. & O'Brien, J. T. (2018).
Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.
Journal of Neurology,
265(7), 1528-1539.
https://doi.org/10.1007/s00415-018-8873-0
Mollenhauer, B., Caspell-Garcia, C. J., Coffey, C. S., Taylor, P., Singleton, A., Shaw, L. M., Trojanowski, J. Q., Frasier, M., Simuni, T., Iranzo, A., Oertel, W., Siderowf, A., Weintraub, D., Seibyl, J., Toga, A. W., Tanner, C. M., Kieburtz, K., Chahine, L. M., Marek, K. ... PPMI Study (2019).
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
Movement Disorders,
34(9), 1354-1364.
https://doi.org/10.1002/mds.27806
Chaudhuri, K. R., Buxton-Thomas, M., Dhawan, V., Peng, R., Meilak, C.
& Brooks, D. J. (2005).
Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: Clinical follow up study of 13 cases.
Journal of Neurology, Neurosurgery & Psychiatry,
76(1), 115-117.
https://doi.org/10.1136/jnnp.2004.046292
Giorgi, F. S., Biagioni, F., Galgani, A.
, Pavese, N., Lazzeri, G. & Fornai, F. (2020).
Locus coeruleus modulates neuroinflammation in parkinsonism and dementia.
International Journal of Molecular Sciences ,
21(22), 1-21. Article 8630.
https://doi.org/10.3390/ijms21228630
Giorgi, F. S., Lombardo, F., Galgani, A., Hlavata, H., Della Latta, D., Martini, N.
, Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., Scalese, M., Bastiani, L., Keilberg, P., De Marchi, D., Fornai, F. & Bonuccelli, U. (2022).
Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects.
Brain Imaging and Behavior,
16(3), 1077-1087.
https://doi.org/10.1007/s11682-021-00562-0
Giorgi, F. S., Martini, N., Lombardo, F., Galgani, A., Bastiani, L., Della Latta, D., Hlavata, H., Busceti, C. L., Biagioni, F., Puglisi-Allegra, S.
, Pavese, N. & Fornai, F. (2022).
Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach.
Journal of Neural Transmission,
129(4), 387-394.
https://doi.org/10.1007/s00702-022-02486-5
Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K.
, Brooks, D. & Pavese, N. (2020).
Levodopa-induced dyskinesias and substantia nigra dopamine D3 receptor availability in Parkinson's disease.
Movement Disorders,
35, S261-S261.
https://doi.org/10.1002/mds.28268
Sommerauer, M. B.
, Hansen, A., Fedorova, T., Knudsen, K., Frederiksen, Y., Damholdt, M. F., Jeppesen, J., Otto, M., Nahimi, A., Brooks, D. & Borghammer, P. (2017).
LBA 39 Noradrenergic deficit in Parkinson’s disease patients with REM sleep behavior disorder is linked to cognitive performance – A 11C - MeN ER PET & neuromelanin MRI study. Abstract from 2017 International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, British Columbia, Canada.
http://www.mdscongress2017.org/Congress-2017-Files/PDF/LBASGGPT.pdf
Bonuccelli, U.
, Pavese, N., Lucetti, C., Renna, M. R., Gambaccini, G., Bernardini, S., Canapicchi, R., Carrozzi, L. & Murri, L. (1999).
Late whiplash syndrome: A clinical and magnetic resonance imaging study.
Functional Neurology,
14(4), 219-225.
Cheesman, A. L., Barker, R. A., Lewis, S. J. G., Robbins, T. W., Owen, A. M.
& Brooks, D. J. (2005).
Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease.
Journal of Neurology, Neurosurgery & Psychiatry,
76(9), 1204-1210.
https://doi.org/10.1136/jnnp.2004.055079
Perraudeau, M., Scott, J., Walport, M., Oakley, C., Bloom, S.
& Brooks, D. (1994).
Late presentation of Kartagener's syndrome.
British Medical Journal,
308(6927), 519-521.
Reuter, I., Hu, M. T. M., Andrews, T. C.
, Brooks, D. J., Clough, C. & Ray Chaudhuri, K. (2000).
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
Journal of Neurology Neurosurgery and Psychiatry,
68(2), 238-241.
https://doi.org/10.1136/jnnp.68.2.238
Glud, A. N., Landau, A. M.
, Johnsen, E. L., Bjarkam, C. R.
, Brooks, D., Kirik, D.
& Sørensen, J. C. H. (2015).
LARGE ANIMAL PARKINSONS DISEASE MODELS USING VIRAL VECTORS AND INOCULATION OF PREFORMED FIBRILS TO MEDIATE ALPHA-SYNUCLEIN OVEREXPRESSION AND MISFOLDING IN THE GOTTINGEN MINIPIG CNS.
Landau, A., Wegener, G., Jakobsen, S., Schacht, AC., Alstrup, AKO., Jacobsen, J., Mørk, A., Sørensen, JC. & Doudet, D. (2012).
Kombineret in vivo PET-mikrodialysestudier af noradrenalinfrisættelse i minigrise. Poster session presented at Psykiatriens 7. Forskningsdag, Risskov, Denmark.
Landau, A. M., Wegener, G., Jakobsen, S., Schacht, A. C.
, Alstrup, A. K. O., Jacobsen, J., Mørk, A.
, Sørensen, J. C. H. & Doudet, D. (2012).
Kombineret in vivo PET-mikrodialyse studier af noradrenalin frisættelse i minigrise. Poster session presented at Psykiatriens 7. Forskningsdag, Aarhus.
Linnet, J., Peterson, E., Bailey, C.
, Gjedde, A. & Møller, A. (2006).
Kliniske. psykologiske og neurobiologiske aspekter af kønsforskelle indenfor ludomani. Poster session presented at Forskningens Dag, Århus, Denmark.
Gjedde, A., Rodell, A.
, Jakobsen, S., Alstrup, A. K. O., Møller, A., Dyve, S.
, Landau, A. M. & Doudet, D. (2010).
Kinetic of Yohimbine binding in porcine brain in vivo.
NeuroImage, (1), 225.
Feeney, C., Scott LeBlanc, G., Raffel, J., Roberts, S., Coello, C., Jolly, A., Searle, G., Goldstone, A. P.
, Brooks, D. J., Nicholas, R. S., Trigg, W., Gunn, R. N. & Sharp, D. J. (2016).
Kinetic analysis of the translocator protein positron emission tomography ligand [F-18]GE-180 in the human brain.
European journal of nuclear medicine and molecular imaging,
43(12), 2201-2210.
https://doi.org/10.1007/s00259-016-3444-z
Ladefoged, O., Strange, P.
, Møller, A., Lam, H. R., Østergaard, G., Larsen, J.-J. & Arlien-Søborg, P. (1991).
Irreversible effects in rats of toluene (inhalation) exposure for six months.
Pharmacology & Toxicology,
68, 384-390.
Horsager, J., Okkels, N., Van Den Berge, N., Jacobsen, J., Schact, A.
, Munk, O. L., Vang, K., Bender, D., Brooks, D. J. & Borghammer, P. (2022).
In vivo vesicular acetylcholine transporter density in human peripheral organs: an [
18F]FEOBV PET/CT study. EJNMMI research,
12(1), Article 17.
https://doi.org/10.1186/s13550-022-00889-9
Koepp, M. J., Hand, K. S. P., Labbé, C., Richardson, M. P., Van Paesschen, W., Baird, V. H., Cunningham, V. J., Bowery, N. G.
, Brooks, D. J. & Duncan, J. S. (1998).
In vivo [11C]Flumazenil-PET correlates with ex vivo [3H]Flumazenil autoradiography in hippocampal sclerosis.
Annals of Neurology,
43(5), 618-626.
https://doi.org/10.1002/ana.410430510
Knudsen, K., Fedorova, T. D., Hansen, A. K., Sommerauer, M.
, Otto, M., Svendsen, K. B., Nahimi, A., Stokholm, M. G., Pavese, N., Beier, C. P.
, Brooks, D. J. & Borghammer, P. (2018).
In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
Lancet Neurology,
17(7), 618-628.
https://doi.org/10.1016/S1474-4422(18)30162-5
Lillethorup, T. P., Glud, A. N., Landeck, N.
, Alstrup, A. K. O., Jakobsen, S., Vang, K., Doudet, D. J.
, Brooks, D. J., Kirik, D., Hinz, R.
, Sorensen, J. C. & Landau, A. M. (2018).
In vivo quantification of glial activation in minipigs overexpressing human alpha-synuclein.
Synapse,
72(12), Article 22060.
https://doi.org/10.1002/syn.22060
Lammertsma, A. A.
, Brooks, D. J., Beaney, R. P., Turton, D. R., Kensett, M. J., Heather, J. D., Marshall, J. & Jones, T. (1984).
In vivo measurement of regional cerebral haematocrit using positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
4(3), 317-322.
https://doi.org/10.1038/jcbfm.1984.47
Cagnin, A.
, Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T. & Banati, R. B. (2001).
In-vivo measurement of activated microglia in dementia.
Lancet,
358(9280), 461-467.
https://doi.org/10.1016/S0140-6736(01)05625-2
Thomsen, M., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M. I. T., Romero-Ramos, M., Brooks, D. J. & Landau, A. (2021).
In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
Journal of Cerebral Blood Flow and Metabolism,
41(4), 819-830.
https://doi.org/10.1177/0271678X20931140
Hansen, A. K., Knudsen, K., Lillethorup, T. P., Landau, A. M., Parbo, P., Fedorova, T., Audrain, H., Bender, D., Østergaard, K.
, Brooks, D. J. & Borghammer, P. (2016).
In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Brain,
139(7), 2039-2049.
https://doi.org/10.1093/brain/aww098
Hansen, A., Knudsen, K., Fedorova, T. D., Parbo, P., Østergaard, K.
, Brooks, D. & Borghammer, P. (2016).
In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Poster session presented at International Congress of Parkinson’s Disease and Movement Disorders, Berlin, Germany.
Gerhard, A.
, Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B.
& Brooks, D. J. (2006).
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Neurobiology of Disease,
21(2), 404-412.
https://doi.org/10.1016/j.nbd.2005.08.002
Gerhard, A., Watts, J., Trender-Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K.
& Brooks, D. J. (2004).
In vivo imaging of microglial activation with [11C](R -PK11195 PET in corticobasal degeneration.
Movement Disorders,
19(10), 1221-1226.
https://doi.org/10.1002/mds.20162
Gerhard, A., Trender-Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P.
& Brooks, D. J. (2006).
In vivo imaging of microglial activation with [11C]-PK11195 PET progresive supranuclear palsy.
Movement Disorders,
21(1), 89-93.
https://doi.org/10.1002/mds.20668
Gjerløff, T.
, Jakobsen, S., Nahimi, A., Munk, O. L., Bender, D., Alstrup, A. K. O., Vase, K. H.
, Brooks, D. J. & Borghammer, P. (2014).
In Vivo Imaging of Human Acetylcholinesterase Density in Peripheral Organs Using 11C-Donepezil: Dosimetry, Biodistribution, and Kinetic Analyses.
Journal of Nuclear Medicine,
55(11), 1818-24.
https://doi.org/10.2967/jnumed.114.143859
Hansen, A. K., Damholdt, M. F., Fedorova, T. D., Knudsen, K., Parbo, P., Ismail, R., Østergaard, K.
, Brooks, D. J. & Borghammer, P. (2017).
In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.
Movement Disorders,
32(6), 922-927.
https://doi.org/10.1002/mds.26961
Pavese, N., Moore, R. Y., Scherfler, C., Khan, N. L., Hotton, G., Quinn, N. P., Bhatia, K. P., Wood, N. W.
, Brooks, D. J., Lees, A. J. & Piccini, P. (2010).
In vivo assessment of brain monoamine systems in parkin gene carriers: A PET study.
Experimental Neurology,
222(1), 120-124.
https://doi.org/10.1016/j.expneurol.2009.12.021
Landau, A., Wegener, G., Alstrup, A. K. O., Jakobsen, S., Audrain, H., Møller, A., Simonsen, M.
, Gjedde, A., Videbech, P. & Doudet, D. (2012).
In vivo alpha2-adrenoceptor-binding viser en forlænget effekt af elektrochok-behandling på den noradrenerge funktion i Göttingen minigrise. Abstract from Psykiatriens 7. Forskningsdag, Risskov, Denmark.
Watson, B. J., Taylor, L. G., Reid, A. G., Wilson, S. J., Stokes, P. R.
, Brooks, D. J., Myers, J. F., Turkheimer, F. E., Nutt, D. J. & Lingford-Hughes, A. R. (2014).
Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET.
Addiction Biology (Online),
19(6), 1032-40.
https://doi.org/10.1111/adb.12073
Del Dotto, P.
, Pavese, N., Gambaccini, G., Bernardini, S., Metman, L. V., Chase, T. N. & Bonuccelli, U. (2001).
Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study.
Movement Disorders,
16(3), 515-520.
https://doi.org/10.1002/mds.1112
Peraza, L. R., Nesbitt, D. J., Lawson, R. A., Duncan, G. W., Yarnall, A. J., Khoo, T. K., Kaiser, M., Firbank, M. J., O'Brien, J. T., Barker, R. A.
, Brooks, D. J., Burn, D. J. & Taylor, J.-P. (2017).
Intra-and Inter-Network Functional Alterations in Parkinson's Disease with Mild Cognitive Impairment.
Human Brain Mapping,
38(3), 1702-1715.
https://doi.org/10.1002/hbm.23499
Hvingelby, V. S., Glud, A. N., Sørensen, J. C. H., Tai, Y.
, Andersen, A. S. M., Johnsen, E., Moro, E.
& Pavese, N. (2022).
Interventions to improve gait in Parkinson's disease: a systematic review of randomized controlled trials and network meta-analysis.
Journal of Neurology,
269(8), 4068–4079 .
https://doi.org/10.1007/s00415-022-11091-1
Gredal, H., Thomsen, B. B., Boza-Serrano, A., Garosi, L., Rusbridge, C., Anthony, D.
, Møller, A., Finsen, B., Deierborg, T., Lambertsen, K. L. & Berendt, M. (2017).
Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke.
NeuroReport,
28(3), 134-140.
https://doi.org/10.1097/WNR.0000000000000728
McGinnity, C. J., Hammers, A., Riaño Barros, D. A., Luthra, S. K., Jones, P. A., Trigg, W., Micallef, C., Symms, M. R.
, Brooks, D. J., Koepp, M. J. & Duncan, J. S. (2014).
Initial Evaluation of 18F-GE-179, A Putative PET Tracer for Activated N-Methyl D-Aspartate Receptors.
Journal of Nuclear Medicine.
https://doi.org/10.2967/jnumed.113.130641
Møller, A., Hansen, L. H., Skrumsager, B., Blatt-Lyon, B. & Pedersen, B. (1990).
Inhibition of photosensitive seizures in man by the ß-carboline, ZK 95962, a selective benzodiazepine receptor agonist.
Epilepsy Res.,
5, 155-159.
Campbell-Meiklejohn, D.
, Simonsen, A., Scheel-Krüger, J., Wohlert, V., Gjerløff, T., Frith, C. D.
, Roepstorff, A., Rogers, R.
& Møller, A. (2012).
In for a penny, in for a pound: methylphenidate reduces the inhibiting effect of high stakes on persistent risky decisions in healthy adults.
Journal of Neuroscience,
32(38), 13032.
https://doi.org/10.1523/JNEUROSCI.0151-12.2012
Fan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K.
, Brooks, D. J. & Edison, P. (2014).
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
Alzheimer's & Dementia.
https://doi.org/10.1016/j.jalz.2014.06.016
Ramlackhansingh, A. F.
, Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G. & Sharp, D. J. (2011).
Inflammation after trauma: Microglial activation and traumatic brain injury.
Annals of Neurology,
70(3), 374-383.
https://doi.org/10.1002/ana.22455
Thomsen, M., Lillethorup, T. P., Wegener, G., Tasker, A. & Landau, A. M. (2015).
Increased receptor density of α2 adrenoceptors and GABAA α5 receptors in limbic brain regions in the domoic acid rat model of epilepsy. Abstract from OAK Meeting 2015, Aarhus, Denmark.
Garvey, L. J.
, Pavese, N., Politis, M., Ramlackhansingh, A.
, Brooks, D. J., Taylor-Robinson, S. D. & Winston, A. (2014).
Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART.
AIDS,
28(1), 67-72.
https://doi.org/10.1097/01.aids.0000432467.54003.f7
Metaxas, A., Thygesen, C., Briting, S. R. R.
, Landau, A., Darvesh, S. & Finsen, B. (2019).
Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients.
Frontiers in Cellular Neuroscience,
13, Article 538.
https://doi.org/10.3389/fncel.2019.00538
Bertelsen, F.
, Møller, A., Folloni, D.
, Drasbek, K. R., Scheel-Krüger, J.
& Landau, A. M. (2017).
Increased GABAA receptor binding in amygdala after prenatal administration of valproic acid to rats.
Acta Neuropsychiatrica,
29(5), 309-3014.
https://doi.org/10.1017/neu.2016.59
Kjaer, T. W., Bertelsen, C., Piccini, P.
, Brooks, D., Alving, J. & Lou, H. C. (2002).
Increased dopamine tone during meditation-induced change of consciousness.
Cognitive Brain Research,
13(2), 255-259.
https://doi.org/10.1016/S0926-6410(01)00106-9
Tomasi, G., Bertoldo, A., Edison, P., Roncaroli, F.
, Pavese, N., Hammers, A., Yen, F. T., Cobelli, C.
, Brooks, D. J., Gerhard, A. & Turkheimer, F. (2007).
Increased binding potential of [11C]PK11195 in Alzheimer disease using a new SRTM accounting for vascular binding.
Journal of Cerebral Blood Flow and Metabolism,
27(SUPPL. 1).
Jalan, R., Turjanski, N., Taylor-Robinson, S. D., Koepp, M. J., Richardson, M. P., Wilson, J. A., Bell, J. D.
& Brooks, D. J. (2000).
Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis.
Gut,
46(4), 546-552.
https://doi.org/10.1136/gut.46.4.546
Callesen, M. B., Weintraub, D.
, Damholdt, M. F. & Møller, A. (2014).
Impulsive and compulsive behaviors among Danish patients with Parkinson’s diseass: Prevalence, depression, and personality.
Parkinsonism & Related Disorders,
20(1), 22-26.
https://doi.org/10.1016/j.parkreldis.2013.09.006
Pagano, G., Molloy, S., Bain, P. G., Rabiner, E. A., Ray Chaudhuri, K.
, Brooks, D. J. & Pavese, N. (2021).
Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study.
Parkinsonism and Related Disorders,
90, 52-56.
https://doi.org/10.1016/j.parkreldis.2021.06.025
Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K.
, Brooks, D. & Pavese, N. (2020).
Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson's disease.
Movement Disorders,
35, S261-S261.
https://doi.org/10.1002/mds.28268
Hammers, A., Koepp, M. J., Free, S. L., Brett, M., Richardson, M. P., Labbé, C., Cunningham, V. J.
, Brooks, D. J. & Duncan, J. (2002).
Implementation and application of a brain template for multiple volumes of interest.
Human Brain Mapping,
15(3), 165-174.
https://doi.org/10.1002/hbm.10016
Nielsen, R. B.
, Parbo, P., Ismail, R., Dalby, R., Tietze, A., Brændgaard, H., Gottrup, H.
, Brooks, D. J., Østergaard, L. & Eskildsen, S. F. (2020).
Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring,
12(1), Article e12032.
https://doi.org/10.1002/dad2.12032
Nielsen, R. B.
, Parbo, P., Ismail, R., Dalby, R., Tietze, A., Braendgaard, H., Gottrup, H.
, Brooks, D. J., Ostergaard, L. & Eskildsen, S. F. (2019).
Impaired perfusion and capillary distribution of blood in mild cognitive impairment: Relation to oxygenation and amyloid load.
Journal of Cerebral Blood Flow and Metabolism,
39(1, suppl.), 147. Article PA00-A28.
https://doi.org/10.1177/0271678X19851017
Eskildsen, S. F., Iranzo, A.
, Stokholm, M. G., Stær, K., Østergaard, K., Serradell, M.
, Otto, M., Svendsen, K. B., Garrido, A., Vilas, D.
, Borghammer, P., Santamaria, J.
, Møller, A., Gaig, C.
, Brooks, D. J., Tolosa, E.
, Østergaard, L. & Pavese, N. (2021).
Impaired cerebral microcirculation in isolated REM sleep behaviour disorder.
Brain : a journal of neurology,
144(5), 1498-1508.
https://doi.org/10.1093/brain/awab054
Playford, E. D., Jenkins, I. H., Passingham, R. E., Frackowiak, R. S.
& Brooks, D. J. (1993).
Impaired activation of frontal areas during movement in Parkinson's disease: a PET study. Advances in neurology,
60, 506-510.
Thomsen, K. R., Lou, H. O. C., Jønsson, M., Hyam, J. A., Holland, P.
, Parsons, C., Young, K. S.
, Møller, A., Stein, A., Green, A. L.
, Kringelbach, M. L. & Aziz, T. Z. (2011).
Impact of Emotion on Consciousness: Positive Stimuli Enhance Conscious Reportability.
P L o S One,
6(4), 1-8.
https://doi.org/10.1371/journal.pone.0018686
Jegindø, E.-M. E., Skewes, J., Wiech, K.
, Lund, T. E., Jensen, M. S., Møller, A., Geertz, A. W., Roepstorff, A. & Jensen, T. S. (2012).
Imaging the Role of Prefrontal Control and Opioidergic Pain Modulation During Prayer. Poster session presented at Human Brain Mapping, Beijing, China.
Lingford-Hughes, A., Hume, S. P., Feeney, A., Hirani, E., Osman, S., Cunningham, V. J., Pike, V. W.
, Brooks, D. J. & Nutt, D. J. (2002).
Imaging the GABA-benzodiazepine receptor subtype containing the α-5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
22(7), 878-889.
https://doi.org/10.1097/00004647-200207000-00013
Alstrup, A. K. O., Landau, A. M., Winterdahl, M., Zeidler, D., Jensen, S. B.
, Munk, O. L. & Sørensen, J. C. H. (2015).
Imaging Techniques with CT, MRI, PET, and SPECT. In
Swine in the laboratory CRC Press Inc..
Alstrup, A. K. O., Winterdahl, M., Simonsen, M.
, Jakobsen, S., Møller, A., Scheel-Krüger, J.
& Landau, A. M. (2011).
Imaging techniques in small and large animals. Abstract from Scandlas Symposium, København, Denmark.
Tai, Y. F.
, Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A.
, Brooks, D. J. & Piccini, P. (2007).
Imaging microglial activation in Huntington's disease.
Brain Research Bulletin,
72(2-3 SPEC. ISS.), 148-151.
https://doi.org/10.1016/j.brainresbull.2006.10.029
Strafella, A. P., Bohnen, N. I.
, Pavese, N., Vaillancourt, D. E., van Eimeren, T., Politis, M., Tessitore, A., Ghadery, C., Lewis, S. & IPMDS‐Neuroimaging Study Group (2018).
Imaging Markers of Progression in Parkinson's Disease.
Movement Disorders Clinical Practice,
5(6), 586-596.
https://doi.org/10.1002/mdc3.12673
Frisoni, G. B., Bocchetta, M., Chételat, G., Rabinovici, G. D., de Leon, M. J., Kaye, J., Reiman, E. M., Scheltens, P., Barkhof, F., Black, S. E.
, Brooks, D. J., Carrillo, M. C., Fox, N. C., Herholz, K., Nordberg, A., Jack, C. R., Jagust, W. J., Johnson, K. A., Rowe, C. C. ... ISTAART's NeuroImaging Professional Interest Area (2013).
Imaging markers for Alzheimer disease: which vs how.
Neurology,
81(5), 487-500.
https://doi.org/10.1212/WNL.0b013e31829d86e8
Stokholm, M. G., Garrido, A., Tolosa, E., Serradell, M., Iranzo, A., Ostergaard, K.
, Borghammer, P., Moller, A., Parbo, P., Staer, K.
, Brooks, D. J., Jose Marti, M.
& Pavese, N. (2020).
Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers.
Journal of Neurology,
267(8), 2296-2300.
https://doi.org/10.1007/s00415-020-09830-3
Gjerløff, T.
, Fedorova, T. D., Knudsen, K., Munk, O. L., Nahimi, A., Jacobsen, S.
, Danielsen, E. H., Terkelsen, A. J., Hansen, J.
, Pavese, N., Brooks, D. J. & Borghammer, P. (2015).
Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.
Brain,
138(3), 653-663.
https://doi.org/10.1093/brain/awu369
Leigh, P. N., Simmons, A., Williams, S., Williams, V., Turner, M.
& Brooks, D. (2002).
Imaging: MRS/MRI/PET/SPECT: Summary.
Amyotrophic Lateral Sclerosis and other Motor Neuron Disorders,
3(SUPPL. 1).
Piccini, P., Del Dotto, P., Bertolucci, A., Bartolini, S., D'Antonio, P.
, Pavese, N. & Bonuccelli, U. (1992).
IL TEST ALL'APOMORFINA SOTTOCUTANEO E SUBLINGUALE NEL MORBO DI PARKINSON.
Rivista di Neurobiologia,
38(6), 527-533.
Wang, Y. M., Yang, Z. Y., Cai, X. L., Zhou, H. Y., Zhang, R. T., Yang, H. X., Liang, Y. S., Zhu, X. Z., Madsen, K. H.
, Sørensen, T. A., Møller, A., Wang, Z., Cheung, E. F. C. & Chan, R. C. K. (2020).
Identifying Schizo-Obsessive Comorbidity by Tract-Based Spatial Statistics and Probabilistic Tractography.
Schizophrenia Bulletin,
46(2), 442-453.
https://doi.org/10.1093/schbul/sbz073
Sigurdsson, H., Yarnall, A., Galna, B., Lord, S., Alcock, L., Morris, R., Lawson, R., Colloby, S., Firbank, M.
, Pavese, N., Brooks, D., O'brien, J., Burn, D. & Rochester, L. (2020).
Identifying neural signatures of Parkinson's disease that predict decline in gait and postural control.
Movement Disorders,
35(Suppl. S1), S281-S282.
https://doi.org/10.1002/mds.28268
Hamdy, S., Rothwell, J. C.
, Brooks, D. J., Bailey, D., Aziz, Q. & Thompson, D. G. (1999).
Identification of the cerebral loci processing human swallowing with H2 15O PET activation.
Journal of Neurophysiology,
81(4), 1917-1926.
https://doi.org/10.1152/jn.1999.81.4.1917
Breen, D. P., Nombela, C., Vuono, R., Jones, P. S., Fisher, K., Burn, D. J.
, Brooks, D. J., Reddy, A. B., Rowe, J. B. & Barker, R. A. (2016).
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease.
Movement Disorders,
31(7), 1062-1066.
https://doi.org/10.1002/mds.26592
Politis, M.
, Pavese, N., Tai, Y. F., Tabrizi, S. J., Barker, R. A. & Piccini, P. (2008).
Hypothalamic involvement in Huntington's disease: An in vivo PET study.
Brain,
131(11), 2860-2869.
https://doi.org/10.1093/brain/awn244
Linnet, J.
, Gjedde, A., Kumakura, Y., Cumming, P.
& Møller, A. (2006).
Hvad sker der i hjernen, når man spiller?. Poster session presented at Forskningens Døgn, Aarhus, Denmark.
Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H. A., Sahakian, B., Hodges, J. R., Rosser, A. E., Wood, N. W.
& Brooks, D. J. (1999).
Huntington's disease progression. PET and clinical observations.
Brain,
122(12), 2353-2363.
https://doi.org/10.1093/brain/122.12.2353
Linnet, J.
, Gjedde, A., Kumakura, Y., Cumming, P.
& Møller, A. (2005).
High sensation seeking men have increased dopamine release in the right putamen during gambling. Poster session presented at High sensation seeking men have increased dopamine release in the right putamen during gambling, Washington DC, United States.
Peterson, E.
, Gjedde, A., Rodell, A., Cumming, P.
, Møller, A. & Linnet, J. (2006).
High sensation seeking men have increased dopamine binding in the right putamen determined from raclopride binding potentials. Poster session presented at 7th Annual Conference on Gambling and Addiction, Las Vegas, United States.
Andersen, K. B., Hansen, A. K., Knudsen, K., Schacht, A. C., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2022).
Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET.
Nuclear Medicine and Biology,
112-113, 52-58.
https://doi.org/10.1016/j.nucmedbio.2022.06.007
Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y.
, Brooks, D. J., Barker, R. A. & Burn, D. J. (2014).
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms.
Movement Disorders,
29(2), 195-202.
https://doi.org/10.1002/mds.25664
Hagell, P., Crabb, L., Pogarell, O., Schrag, A., Widner, H.
, Brooks, D. J., Oertel, W. H., Quinn, N. P. & Lindvall, O. (2000).
Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease.
Movement Disorders,
15(2), 224-229.
https://doi.org/10.1002/1531-8257(200003)15:2<224::AID-MDS1004>3.0.CO;2-W
Marazziti, D., Toni, C., Pedri, S., Bonuccelli, U.
, Pavese, N., Nuti, A., Muratorio, A., Cassano, G. B. & Akiskal, H. S. (1995).
Headache, panic disorder and depression: Comorbidity or a spectrum? Neuropsychobiology,
31(3), 125-129.
https://doi.org/10.1159/000119182
Bhatia, K.
, Brooks, D. J., Burn, D. J., Clarke, C. E., Playfer, J., Sawle, G. V., Schapira, A. H. V., Stewart, D. & Williams, A. C. (1998).
Guidelines for the management of Parkinson's disease.
Hospital Medicine,
59(6), 469-480.
Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R.
, Brooks, D. J. & Duncan, J. S. (2003).
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients.
Brain,
126(6), 1300-1318.
https://doi.org/10.1093/brain/awg138
Duncan, G. W., Firbank, M. J., Yarnall, A. J., Khoo, T. K.
, Brooks, D. J., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2016).
Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Movement Disorders,
31(1), 103-110.
https://doi.org/10.1002/mds.26312